Latest Diabetes mellitus type 2 Stories
A new study, the first of its kind, shows bariatric surgery dramatically outperforms standard medical practices when treating Type 2 diabetes. Researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center conducted the study and published their findings Monday in an advanced online edition of the New England Journal Medicine (NEJM). The study reports a majority of the patients who received bariatric surgery were all to...
First-of-its-kind study also shows surgery results in fewer medications, greater weight loss after 1 year Bariatric or "metabolic" surgery is more effective than intensive medical management alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after one year, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings...
Programs to prevent or delay type 2 diabetes in high-risk adults would result in fewer people developing diabetes and lower health care costs over time, researchers conclude in a new study funded by the National Institutes of Health. Prevention programs that apply interventions tested in the landmark Diabetes Prevention Program (DPP) clinical trial would also improve quality of life for people who would otherwise develop type 2 diabetes. The analysis of costs and outcomes in the DPP and...
SAN DIEGO and INDIANAPOLIS, March 23, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted marketing authorization to BYETTA® (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos® (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents. "The...
GREENVILLE, N.C., March 22, 2012 /PRNewswire-USNewswire/ -- More than 8 percent of U.S. adults have diabetes. In North Carolina, the rate is even higher, at 9.6 percent. Among the state's African American adults, the rate is a staggering 15.6 percent.[1] In rural eastern North Carolina, the toll is even greater: the adjusted mortality rate from diabetes is 42 times higher than in other areas. Ten years ago, a small group of clinicians, diabetes educators and practice managers from...
PARSIPPANY, N.J., March 9, 2012 /PRNewswire/ -- Chef Franklin Becker of the Two Reasons, One Recipe campaign is pleased to name Lorin Cook of Alpine, N.J. the grand prize winner of the Franklin's Family Fixin's Contest in which adults living with type 2 diabetes and/or high LDL cholesterol - or their family, friends or caretakers - were invited to receive a healthy makeover of their traditional family favorites. To view the multimedia assets associated with this release, please...
International phase 3 trial is largest study ever of rare endocrine disorder A new investigational drug significantly reduced urinary cortisol levels and improved symptoms of Cushing's disease in the largest clinical study of this endocrine disorder ever conducted. Results of the clinical trial conducted at centers on four continents appear in the March 8 New England Journal of Medicine and show that treatment with pasireotide cut cortisol secretion an average of 50 percent and returned...
Metformin treatment seen to prevent growth of calcium deposits in coronary arteries Treatment with the common diabetes drug metformin appears to prevent progression of coronary atherosclerosis in patients infected with HIV. In a presentation today at the 19th Conference on Retroviruses and Opportunistic Infections, Massachusetts General Hospital (MGH) researchers reported that study participants receiving daily doses of metformin had essentially no progression of coronary artery...
